Quest Diagnostics named Adrienne Brott its SVP and chief quality and regulatory affairs officer. She will oversee the firm's quality and regulatory strategy, as well as its efforts complying with US ...
NEW YORK — Following extraordinary demand for rapid COVID-19 antigen testing in 2021, Siemens Healthineers reported on Wednesday that the company's fiscal third quarter COVID-19 testing revenue ...
NEW YORK – Although their highly sensitive platform for antigen detection was developed before the COVID-19 pandemic, researchers in Ping Wang's laboratory at the University of Pennsylvania saw a ...
NEW YORK — Dutch molecular diagnostics firm Genome Diagnostics said on Friday that it has received a European Union Quality Management System Certificate under the new In Vitro Diagnostic Medical ...
NEW YORK – This fall the Biden administration released its 2022 Biodefense Strategy and Implementation Plan, laying out its goals for responding to future pandemics and other biological threats. The ...
NEW YORK – In an effort to help alleviate pandemic-related sample prep bottlenecks, researchers at the National Institutes of Health have developed a direct-from-sample testing protocol utilizing a ...
NEW YORK – The COVID-19 pandemic drove massive amounts of public and private investment into the diagnostics industry as the US and world saw unprecedented demand for testing. That investment ...
NEW YORK – After receiving the first ever Emergency Use Authorization for a SARS-CoV-2 breath test from the US Food and Drug Administration, InspectIR is planning out its next steps toward ...
NEW YORK — Canadian healthcare firm Switch Health said on Wednesday that it has partnered with Anven Biosciences to develop a new class of artificial antibodies for use in point-of-care SARS-CoV-2 ...
NEW YORK – The National Institutes of Health Rapid Acceleration of Diagnostics initiative has launched a new study aimed at determining how at-home rapid antigen testing for SARS-CoV-2 compares with ...
NEW YORK – Danaher subsidiary Leica Biosystems said Monday that it secured US Food and Drug Administration 510(k) clearance for its Bond MMR Antibody Panel to help identify potential Lynch syndrome in ...
RNA Disease Diagnostics has appointed Dipanjan Pan, its chief scientific advisor, and John Erickson, its president, to the board of directors. Pan is a professor of diagnostic radiology and nuclear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results